Европейски съюз - естонски - EMA (European Medicines Agency)

zoetis belgium sa - live nõrgenenud aujeszky haiguse viirus - immunoloogilised vahendid - sead - sigade aktiivne immuniseerimine alates 10 nädala vanusest, et vältida aujeszky haiguse suremust ja kliinilisi tunnuseid ning vähendada aujeszky haiguse väliuuringu viiruse. vaktsineeritud noorte ja emiste järglaste passiivne immuniseerimine, et vähendada aujeszky haiguse suremust ja kliinilisi tunnuseid ning vähendada aujeszky haiguse põldviiruse eritumist.

Европейски съюз - естонски - EMA (European Medicines Agency)

medimmune llc - reassortant gripi viirus (live nõrgenenud) järgmisi tüvesid:a/california/7/2009 (h1n1)pdm09, nagu tüvi, a/victoria/361/2011 (h3n2) nagu tüvi, b/massachusetts/2/2012 meeldib tüvi - influenza, human; immunization - vaktsiinid - gripi profülaktika 24 kuud kuni alla 18-aastastele inimestele. kasutada fluenz aluseks peaks olema euroopa liidu soovitusi.

Европейски съюз - естонски - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - muudetud live veiste viiruslik kõhulahtisus viiruse tüüp 1, mitte-cytopathic algtüve ke-9 ja modifitseeritud live veiste viiruslik kõhulahtisus virus tüüp 2, mitte-cytopathic algtüve ny-93 - immunoloogilised ravimid jaoks bovidae, live viral vaccines - aktiivse immuniseerimise veiseid alates 3 kuu vanusest vähendada hyperthermia ja vähendada vähendada leukotsüütide arv, mis on põhjustatud veiste viiruslik kõhulahtisus viiruse (bvdv-1 ja bvdv-2), ja vähendada viiruse levikuga ja viraemia põhjustatud bvdv-2. veiste aktiivseks immuniseerimiseks bvdv-1 ja bvdv-2 vastu, et vältida püsivalt nakatunud vasikate sündi, mis on põhjustatud transplatsentaarsest infektsioonist.

Европейски съюз - естонски - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - rekombinantse türgi herpesvirus, tüvi vhvt013-69, live - immunoloogilised ravimid jaoks linnud, kodukana, immunoloogilised ravimid - embryonated eggs; chicken - aktiivse immuniseerimise kanade:selleks, et ära hoida suremust ja vähendada kliinilisi tunnuseid ja kahjustused nakkav haiguse bursal. vähendada suremust, kliinilisi tunnuseid ja kahjustuste marek tõbi.

Европейски съюз - естонски - EMA (European Medicines Agency)

intervet international b.v. - raku seotud live rekombinantse türgi herpesvirus (tüvi hvp360), väljendades fusion valk nd viiruse ja vp2 valgu kohta ibd viirus - lindude herpes viirus (marek tõbi) + lindude nakkav bursal haiguse viiruse (gumboro haigus) + newcastle ' i haiguse viiruse/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Европейски съюз - естонски - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaktsiinid - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 ja 4. kasutada dengvaxia peab olema kooskõlas ametlike soovitustega.

Европейски съюз - естонски - EMA (European Medicines Agency)

bavarian nordic a/s - vibrio cholerae, tüvi cvd 103-hgr, live - cholera - vaktsiinid - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. selle vaktsiini tuleb kasutada vastavalt ametlikele soovitustele.

Европейски съюз - естонски - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunoloogilised ained - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Европейски съюз - естонски - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunoloogilised ained - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Европейски съюз - естонски - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.